Vertex Pharmaceuticals
VRTX
VRTX
395 hedge funds and large institutions have $15.8B invested in Vertex Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 152 increasing their positions, 143 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
395
Holders Change
+9
Holders Change %
+2.33%
% of All Funds
11.42%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
42
Increased
152
Reduced
143
Closed
28
Calls
$388M
Puts
$365M
Net Calls
+$23.3M
Net Calls Change
-$46.3M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$174M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$86.5M |
| 3 |
D.E. Shaw & Co
New York
|
+$83.1M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$63.1M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$58.4M |
Top Sellers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$152M |
| 2 |
JPMorgan Chase & Co
New York
|
-$111M |
| 3 |
Jennison Associates
New York
|
-$61.6M |
| 4 |
GVI
Green Valley Investors
Wilmington,
Delaware
|
-$56M |
| 5 |
Goldman Sachs
New York
|
-$53.9M |
